Browsed by
Tag: Skin Cancer Prevention

A Protocol for a Facebook Intervention for Young Melanoma Survivors and Their Families

A Protocol for a Facebook Intervention for Young Melanoma Survivors and Their Families

Individuals diagnosed with melanoma before the age of 40 (young-onset melanoma survivors) and their first-degree relatives (FDRs) are a growing population at risk for developing recurrent melanoma or new melanomas. Regular surveillance using clinical skin examination (CSE) and skin self-examination (SSE), and engagement in preventive behaviors including sun protection are recommended. Given the growing population of young melanoma survivors and their families who are at increased risk, it is surprising that no behavioral interventions have been developed and evaluated to improve risk-reduction behaviors.

In response, 16 researchers from ten institutions and organizations have developed an intervention and published its protocol in JMIR Research Protocols. Ultimately, the intervention is designed to improve skin cancer prevention and screening for young-onset melanoma survivors and their families. The authors believe the intervention’s delivery via Facebook will increase its impact because of the dissemination potential.

The randomized controlled trial will evaluate the efficacy of a Facebook intervention providing information, goal setting, and peer support to increase CSE, SSE, and sun protection for young-onset melanoma survivors and their FDRs. A sample of over 500 melanoma survivors and their FDRs will be randomly assigned to either the Young Melanoma Family Facebook Group or another Facebook group control condition. Before and after the intervention, study participants will complete measures of CSE, SSE, sun protection, attitudes, and beliefs. An additional objective is to evaluate the efficacy of the Facebook interventions on perceived stress, physical activity, and healthy eating behaviors.

The authors plan to complete study enrollment by late 2023. Data analysis will employ multilevel modeling with family as the upper-level sampling unit and individual as the lower-level sampling unit. According to the authors, “Fixed effect predictors in these models will include condition, role, sex, all 2- and 3-way interactions, and covariates.” If effective, the Young Melanoma Family Facebook program could be disseminated by dermatology practices, public health and nonprofit melanoma organizations, and existing melanoma and skin cancer Facebook groups, expanding its reach.

Paper Authors and Affiliations

Dr. Sharon Manne, Dr. Carolyn Heckman, Sara Frederick, Mara Domider, and Marissa Grosso:  Behavioral Sciences, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, New Jersey

Dr. Sherry Pagoto:  Department of Allied Health Sciences, College of Agriculture, Health and Natural Resources, University of Connecticut, Storrs, Connecticutt

Dr. Susan Peterson:  Department of Behavioral Science, Division of Cancer Prevention and Population Sciences, MD Anderson Cancer Center, The University of Texas, San Antonio, Texas

Dr. Deborah Kashy:  College of Social Science, Department of Psychology, Michigan State University, East Lansing, Michigan

Dr. Adam Berger:  Division of Surgical Oncology, Department of Surgery, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, New Jersey

Dr. Christina Studts: Pediatrics – General Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado

Dr. Rosalyn Negron: College of Liberal Arts, University of Massachusetts Boston, Boston, Massachusetts

Dr. David Buller: Klein Buendel, Inc, Golden, Colorado

Dr. Lisa Paddock and Alexandria Kulik: Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey

Joseph Gallo: Hackensack Meridian Jersey Shore Medical Center, Hackensack Meridian Health, Neptune City, New Jersey

Morgan Pesanelli: School of Public Health, Rutgers, The State University of New Jersey, New Brunswick, New Jersey

This project was supported by a grant from the National Cancer Institute to Rutgers University (CA221854; Dr. Sharon Manne, Principal Investigator). Dr. David Buller, Klein Buendel Director of Research, is a Co-Investigator on the project.

Collaborator Spotlight:
Dr. Alexandra Morshed

Collaborator Spotlight:
Dr. Alexandra Morshed

Alexandra Morshed, Ph.D., is a Research Assistant Professor in the Department of Behavioral, Social and Health Education Services at Emory University. She is also a Co-Investigator with the Emory Prevention Research Center. Dr. Morshed received her Master of Science degree from Wageningen University in the Netherlands and her Ph.D. from Washington University in St. Louis.

Dr. Alexandra Morshed

Dr. Morshed is an implementation scientist with more than ten years of experience in public health research and practice. Her primary areas of interest include implementing interventions in vulnerable populations, chronic disease prevention, public health nutrition, and capacity building and knowledge expansion in dissemination and implementation science.

Dr. Morshed is currently collaborating with Dr. David Buller from Klein Buendel on a research study titled “Go Sun Smart at Work: A Sun Safety Program for Underserved Outdoor Workers” (Dr. Morshed and Dr. Buller, Multiple Principal Investigators). This CDC-funded study builds upon Klein Buendel’s evidence-based comprehensive occupational skin cancer prevention intervention, Go Sun Smart at Work, and aims to reduce UV exposure and prevent skin cancer among underserved outdoor workers in Georgia. Hispanic and African American adults have been overlooked in skin cancer prevention efforts, due to their lower incidence of skin cancer. However, among Hispanic and African Americans, skin cancer is diagnosed at more advanced stages, leading to higher mortality rates than non-Hispanic whites. The Emory University study aims to develop an intervention and implementation strategies to increase policies and practices to support sun safety among outdoor workers in Georgia.

UV Measured under Built Shade in Public Parks

UV Measured under Built Shade in Public Parks

Reducing exposure to ultraviolet radiation (UV) is crucial for preventing UV-induced diseases of the skin and eyes. Shade may offer significant protection from UV.

A research team from Klein Buendel and Cancer Council Victoria and LaTrobe University in Australia have published a paper on UV measurements under shade structure built in public parks in International Journal of Environmental Research and Public Health. The paper expands empirical research to quantify the UV protection offered from built shade to guide disease prevention practices and confidence in investment in shade.

Specifically, the research team quantified UV levels under built shade relative to unshaded passive recreation areas (PRAs) over summer months in parks in two cities (Denver, Colorado, USA and Melbourne, Victoria, Australia). In a randomized controlled trial, 1,144 UV measurements were recorded at the center and periphery of PRAs in a total sample of 144 public parks as part of pretest and posttest measures of use of the PRAs by park visitors. UV measurements were recorded for three recruitment waves per city during 2010 to 2014. Following pretest, 36 of the PRAs received built shade structures.

Regression analyses modelled pre-post change in UV (Standard Erythemal Dose (SED) per 30 min) at PRAs; and environmental predictors. Mean UV at the center of built shade PRAs decreased from pretest to posttest, adjusting for the covariates of ambient SED, solar elevation, and cloud cover. Clouds decreased and solar elevation increased UV levels under shade. No significant differences in UV by design of the shade structure occurred. A substantial reduction in UV exposure can be achieved using built shade with shade cloth designs, offering considerable protection for shade users. Supplementary sun protection  is recommended for extended periods of shade use during clear sky days. This could include things like brimmed hats, long sleeves, sunglasses, and sunscreen.

This research was supported by a grant from the National Cancer Institute (CA140367; Dr. David Buller, PI). Collaborators on this publication also include Dr. Suzanne Dobbinson and Dr. James Chamberlain from Cancer Council Victoria; Jody Simmons from LaTrobe University; and Mary Buller from Klein Buendel.

Indoor Tanning Policy and the Impact of COVID-19 on Tanning Facilities

Indoor Tanning Policy and the Impact of COVID-19 on Tanning Facilities

Julia Berteletti from Klein Buendel presented findings from a study on U.S. indoor tanning legislation efforts related to reduced indoor tanning by minors at the 43rd Annual Meeting & Scientific Sessions of the Society of Behavioral Medicine in Baltimore, MD, April 6-9 2022.

Skin cancer is a significant and expensive public health problem, with approximately 5 million Americans treated at a cost of over $8 billion annually. Indoor tanning (IT) is a well-established cause of melanoma and keratinocyte carcinomas.

Julia Berteletti Presenting at SBM

IT is regulated in two main ways: states restricting minor access and the U.S. Food and Drug Administration (FDA) regulations to minimize harm. Since 2012, 22 states and the District of Columbia adopted IT bans for all minors, ten banned some minors by age, and 12 required parental consent/accompaniment, but six have no law, primarily due to failed legislation. Seven states proposed new legislation in 2021. Additionally, FDA regulations (e.g., protective eyewear, session duration) exist to minimize harm from IT devices.

Recent evidence suggests that more stringent laws (for example, age bans vs. parental consent laws) are associated with less youth IT. Policy enforcement provisions and compliance with policies are also essential components of effective IT policy implementation, but enforcement and compliance are currently variable and inadequate. We are currently coding 102 state IT law documents that were proposed, passed, or failed, and 4 accompanying regulatory documents, using a validated coding tool. Documents are being assessed for regulation stringency, type of ban, warnings provided, operator requirements, and enforcement provisions.

Additionally, results show that beginning in March, 2020, in addition to state-level mandates, there have been additional guidelines and restrictions for IT salons due to the COVID-19 pandemic.  From March 2020 to April 2020, 49 states and the District of Columbia required salons to close to customers and reopened between April 2020 and December 2020 with varying restrictions, such as requiring appointments for services, requiring patrons to wear masks in public areas, and increasing ventilation in salons. Enforcement of these pandemic restrictions is unclear. Restrictions likely resulted in permanent salon closures and lower IT rates in 2020 but it is unknown how IT rates will be affected long-term, especially given the option for home tanning. Additional descriptive results of the policy coding and COVID-19 restrictions will be presented.

These data will help determine whether certain bill characteristics such as stringency or enforcement requirements are associated with law passage or not or bill stringency has increased over time, and the initial impact of the pandemic on IT policies. These findings will have implications for IT behavior and, ultimately, skin cancer incidence.

This research is funded by the National Cancer Institute (CA244370; Dr. Carolyn Heckman, Rutgers University, and Dr. David Buller, Klein Buendel, Multiple Principal Investigators). Authors collaborating on this conference poster include Julia Berteletti and Allyson Montalvo from Klein Buendel; and Anna Mitarotondo from Rutgers University.

Collaborator Spotlight:
Dr. Yelena Wu

Collaborator Spotlight:
Dr. Yelena Wu

Yelena Wu, PhD, is an Associate Professor in the Department of Dermatology at the University of Utah and a Research Investigator at the Huntsman Cancer Institute. She received a BA in Psychology from the University of California, Berkeley, and an MA and PhD in Clinical Child Psychology from the University of Kansas. She is also a licensed pediatric and clinical child psychologist.

Dr. Wu’s research and clinical practice center on promoting better health outcomes for children, adolescents, and young adults who have a history of cancer or who are at risk for developing cancer. A specific area of research interest is the prevention of skin cancer by improving adherence to preventive behavior recommendations among children and adolescents at increased risk for developing skin cancer.

Dr. Wu is currently the Principal Investigator on a 5-year project funded by National Cancer Institute (CA244674) to test a school-based program designed to increase adolescents’ use of sun protection and decrease participation in intentional tanning. Dr. David Buller, director of Research at Klein Buendel, collaborates as a Co-Investigator on the project.

In addition to her research, Dr. Wu provides consultations and therapeutic services to medical teams, patients, and caregivers to facilitate communication and aid in the management of cancer through the Family Cancer Assessment Clinic at the Huntsman Cancer Institute.

Collaborator Spotlight:
Dr. Carolyn Heckman

Collaborator Spotlight:
Dr. Carolyn Heckman

Dr. Carolyn J. Heckman is an Associate Professor of Medicine and Co-Leader of the Cancer Prevention and Control Program at the Rutgers Cancer Institute of New Jersey. She received a BA in Psychology from Brown University and PhD in Counseling Psychology from the University of Iowa. She completed a postdoctoral fellowship in health psychology and addictions at Virginia Commonwealth University. She is also a licensed psychologist.

Dr. Heckman has published more than 100 research papers and presented at many national and international conferences. Much of her work focuses on skin cancer prevention and detection. Her other interests include online interventions and tobacco use and cessation. She has been funded numerous times by the National Cancer Institute and has also received funding from the American Cancer Society and Pfizer, Inc.

In addition to her research, Dr. Heckman is a member of the NIH Community Level Health Promotion study section and she is on the Editorial Board of the journal Translational Behavioral Medicine. She is the Founder/Leader of the Cancer Institute of New Jersey’s Dissemination and Implementation Science Working Group. Dr. Heckman has served on several steering and advisory, grant review, search committee, training, and other committees and community groups. For example, she served as the National Chair of the Don’t Fry Day skin cancer prevention awareness campaign sponsored by the National Council on Skin Cancer Prevention.

Currently, Dr. Heckman is a Co-Investigator on a five-year R01 study called “A Multi-Level Investigation of U.S. Indoor Tanning Policy Enactment, Implementation, Compliance, Impact, and Economics” with Klein Buendel’s Dr. David Buller. The goals of this research project are to complete three specific aims: 1) conduct a comparative case study to elucidate the indoor tanning legislation adoption process; 2) use a pseudo-patron (confederate) assessment, national survey, and archival data to investigate indoor tanning legislation implementation, as well as indoor tanning and sunburn outcomes among adolescents and young adults; and 3) integrate data from the first two aims and external data to assess economic effects relevant to policy sustainability of indoor tanning stringency, enforcement, and compliance.

This image has an empty alt attribute; its file name is spotlight_text.jpg
Persisting Effects of the Health Chat Program

Persisting Effects of the Health Chat Program

The use of indoor tanning facilities by minors is a public health concern. In an effort to reduce risk for skin cancer, the Health Chat social media intervention was launched by Klein Buendel researchers and their colleagues to reduce mothers’ permissiveness toward their teenage daughters’ indoor tanning behavior.

For the Health Chat study, mothers with daughters aged 14-17 were recruited in 34 states that do not ban indoor tanning by minors. Participating mothers received an adolescent health social media campaign in Facebook private groups. Half of the mothers were in a group in which the health campaign included posts about preventing indoor tanning (intervention) and the other half, included posts on preventing prescription drug misuse (control). Follow-up surveys with mothers at 12 months and 18 months measured indoor tanning permissiveness, attitudes, intentions, communication, behavior, and support for state indoor tanning bans.

Analysis of the 18-month follow-up data from the Health Chat social media intervention was e-published recently in Cancer Epidemiology, Biomarkers & Prevention. The research was led by Dr. David Buller from Klein Buendel and Dr. Sherry Pagoto from the University of Connecticut.

The methods and results of this randomized trial are detailed in the publication. Data analysis showed that at 18 months after the intervention, mothers in the intervention group were less permissive of indoor tanning by daughters and had greater self-efficacy to refuse daughter’s indoor tanning requests than mothers in the control group. Intervention-group mothers also had lower intentions to indoor tan themselves and were more supportive of bans on indoor tanning by minors than control-group mothers. In addition, daughters in the intervention group expressed less positive attitudes toward indoor tanning than daughters in the control group.

In summary, the Health Chat social media intervention may have influenced mothers’ decisions to withhold permission for their daughters to indoor tan for six months after the end of the program. Mothers’ support for bans on indoor tanning by minors also appears to have persisted.

This research was funded by a grant and supplement from the National Cancer Institute (CA192652; Dr. David Buller and Dr. Sherry Pagoto, Multiple Principal Investigators). Collaborating authors include Dr. Katie Baker and Dr. Joel Hillhouse from East Tennessee State University; Dr. Kimberly Henry from Colorado State University; Jessica Bibeau from the University of Connecticut; and Dr. Barbara Walkosz, Julia Berteletti and Alishia Kinsey from Klein Buendel. 

Family Attitudes and Communication about Sun Protection

Family Attitudes and Communication about Sun Protection

Young melanoma survivors and their families are at increased risk for developing melanoma, yet do not often practice sun protection for skin cancer prevention. Currently, little is known about the role of family interaction in sun protection.

Klein Buendel Senior Scientist, Dr. David Buller, was one of several authors on a recent paper on family attitudes and communication about sun protection among young melanoma skin cancer survivors and their family members e-published in the Journal of Health Communication. The research team was led by Dr. Sharon Manne from the Department of Medicine, Behavioral Sciences Section at the Rutgers Cancer Institute of New Jersey.

The research team set out to “examine correspondence between survivors and family sun protection, individual attitudes, and family attitudes and communication about risk-reducing behaviors, and evaluate the mediating role of family attitudes and communication in the association between individual sun protection attitudes and behavior.” Participants completed questionnaires about their individual attitudes, family attitudes and communication, and sun protection behaviors.  

Analyses showed that families had varying levels of shared attitudes and behaviors. Family discussion was associated with higher sun protection for both men and women. Other findings differed for men vs. women and cancer survivors vs. family members. Full descriptions of the measures, methods, results, and conclusions can be found in the publication. Overall, the authors believe that family-focused interventions may prove effective because families’ attitudes and practices correspond with each other.

This research was supported by a grant from the National Institutes of Health (Dr. Sharon Manne, Principal Investigator). Other authors on the publication include Dr. Deborah Kashy from Michigan State University; Dr. Sherry Pagoto from the University of Connecticut; Dr. Susan Peterson from the University of Texas MD Anderson Cancer Center; Dr. Carolyn Heckman, Joseph Gallo, Dr. Adam Berger, Alexandria Kulik, Sara Frederick, and Morgan Pesanelli from the Rutgers Cancer Institute of New Jersey; and Dr. David Buller from Klein Buendel.

Workplace Sun Safety Training Goes All-Virtual

Workplace Sun Safety Training Goes All-Virtual

People who work outdoors are exposed to high levels of solar ultraviolet radiation (UV) over a lifetime that can substantially increase their risk for developing skin cancer. Workplaces can be an effective channel for UV safety policy and training for employees in order to reduce their UV over-exposure and risk for skin cancer.

Klein Buendel researchers and their collaborators have been developing, evaluating, and refining comprehensive approaches to occupational sun protection for two decades. Now, the experienced research team is launching a new project funded by the National Cancer Institute to develop and evaluate a mechanism for distributing an established sun protection program virtually to diverse workplaces in the United States. The virtual environment will be comprised of a database, content management (interactive toolbox), and media platform (trackable training) to tailor the sun safety program to management’s readiness to innovate on sun safety based on Diffusion of Innovations Theory. In addition, the virtual platform will better integrate sun safety training by improving appropriateness for Hispanic and African American workers and conforming with the latest learning management systems technologies.

The Fast-Track SBIR project (CA257778) will complete a 9-month Phase I feasibility study and a 2-year Phase II effectiveness trial through employers across the country. The primary hypothesis of the study is that compared to employers in a minimal information control group, employers assigned to receive SSW Works will have employees that practice more sun protection at posttest. The research will be led by Mary Klein Buller, Principal Investigator. Co-Investigators include Dr. Barbara Walkosz, Julia Berteletti, and Dr. David Buller from Klein Buendel. The virtual platform will be engineered by Klein Buendel’s Creative Team.

The outdoor workforce in the United States is large and, in many places, at very high risk for skin cancer. Improving sun safety will help reduce health care costs and save lives. Thus, the research will have high impact and potential for commercial adoption, two objectives of SBIR projects.

Adopting Policy to Eliminate Indoor Tanning

Adopting Policy to Eliminate Indoor Tanning

Dr. David Buller from Klein Buendel joined two other behavioral scientists to publish a Viewpoint in JAMA Dermatology in April calling on dermatologists and others to support legislative efforts and other policies in their local areas to help dramatically curtail indoor tanning in the United States. The other two authors were Dr. Carolyn Heckman from the Rutgers Cancer Institute of New Jersey and Dr. Jerod Stapleton from the University of Kentucky.

The Viewpoint describes policy and regulation as “among the most effective strategies for influencing health behaviors and public health.” Indoor tanning restrictions in multiple states are helping to reduce skin cancer incidence and death.  Achieving continued and additional restrictions will require concerted research, advocacy, and policy efforts to overcome remaining barriers to new laws and to close lingering gaps in existing laws.

In their editorial, the authors put out a Call to Action to dermatologists to increase their awareness of local indoor tanning laws, or lack thereof, and to educate their patients, legislators, school boards, local business groups, and others about the dangers of indoor tanning and the need for more restricted use, especially by minors.

The Viewpoint was published online in JAMA Dermatology on April 28, 2021.